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Abstract
Pseudomonas aeruginosa, a ubiquitous bacteria found in diverse ecological niches, is an important cause of acute infections
in immunocompromised individuals and chronic infections in patients with Cystic Fibrosis. One signaling molecule required
for the coordinate regulation of virulence factors associated with acute infections is 39, 59-cyclic adenosine monophosphate,
(cAMP), which binds to and activates a catabolite repressor homolog, Vfr. Vfr controls the transcription of many virulence
factors, including those associated with Type IV pili (TFP), the Type III secretion system (T3SS), the Type II secretion system,
flagellar-mediated motility, and quorum sensing systems. We previously identified FimL, a protein with histidine
phosphotransfer-like domains, as a regulator of Vfr-dependent processes, including TFP-dependent motility and T3SS
function. In this study, we carried out genetic and physiologic studies to further define the mechanism of action of FimL.
Through a genetic screen designed to identify suppressors of FimL, we found a putative cAMP-specific phosphodiesterase
(CpdA), suggesting that FimL regulates cAMP levels. Inactivation of CpdA increases cAMP levels and restores TFP-dependent
motility and T3SS function to fimL mutants, consistent with in vivo phosphodiesterase activity. By constructing
combinations of double and triple mutants in the two adenylate cyclase genes (cyaA and cyaB), fimL, and cpdA, we show
that DfimL mutants resemble DcyaB mutants in TM defects, decreased T3SS transcription, and decreased cAMP levels.
Similar to some of the virulence factors that they regulate, we demonstrate that CyaB and FimL are polarly localized. These
results reveal new complexities in the regulation of diverse virulence pathways associated with acute P. aeruginosa
infections.
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Introduction
Pseudomonas aeruginosa is an important human pathogen found
throughout the environment in diverse ecological niches and is
associated with severe opportunistic infections [1]. Patients with
some degree of immunocompromise and epithelial barrier injury,
such as those with severe burns or surgical incisions, on
mechanical ventilation, or receiving cytotoxic chemotherapy, are
particularly vulnerable to acute infection. This Gram-negative
bacterium is also the leading cause of chronic pulmonary
infections and death in Cystic Fibrosis patients. Even with
appropriate medical treatment, mortality remains high and
antibiotic resistance is increasingly common. Thus, it is of great
importance to identify new potential therapeutic targets.
P. aeruginosa produces several virulence factors associated with
acute infection, including components of the Type IV pilus (TFP),
Type III secretion system (T3SS), Type II secretion system (T2SS),
and quorum sensing systems (reviewed in [2]). TFP are polarly
localized appendages composed of pilin polymers that undergo
reversible assembly and disassembly and allow the bacteria to
move over a solid surface in a process termed twitching motility
(TM) (reviewed in [3]). In addition, TFP function as phage
receptors, are initiators of biofilm formation, and are the primary
adhesins associated with P. aeruginosa binding to both biotic and
abiotic surfaces, including mammalian cells. The T2SS functions
to secrete enzymes such as proteases, hemolysins and toxins into
the extracellular milieu to cause host cell cytotoxicity. The T3SS,
which resembles a molecular syringe, directly injects effector
proteins, including ExoU, ExoS, ExoT, and ExoY, from the
bacteria to the host cell cytosol. Components of related T3SS in
Shigella flexneri and Yersinia pestis have been shown to localize to the
cell pole [4,5]. These effector proteins have profound outcomes on
host cell signaling, leading to host cell death and alterations in the
host immune system. The bacterial molecules involved in the
activation and coordination of virulence factor production include
numerous signal transduction cascades [6].
One signaling molecule required for the coordinate regulation
of virulence factors associated with acute infections is 39, 59-cyclic
adenosine monophosphate, (cAMP). cAMP functions as a co-
factor for the cAMP binding protein, variously known as CAP or
CRP. Upon binding cAMP, CRP undergoes a conformational
change and binds to specific DNA sequences, thus modulating
gene transcription. cAMP signaling has also been shown to
regulate a variety of processes in many bacteria, from iron uptake
in E. coli [7] to competence in Haemophilus influenzae [8]. cAMP
signaling in the regulation of the lac operon during diauxic growth
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[9] and in catabolite repression [10] has been extensively studied
in Escherichia coli and other bacteria. More recently, cAMP
signaling has been implicated in the regulation of virulence factors
for many pathogenic firmicutes and proteobacteria, although the
mechanisms vary widely [10].
In P. aeruginosa, cAMP is an allosteric regulator of the CRP
homolog, Vfr (virulence factor regulator) [11]. In contrast to E.
coli, cAMP signaling in P. aeruginosa is not involved in catabolite
repression. Instead, Vfr controls the transcription of over 200
genes, including those associated with TFP, T3SS, T2SS, flagellar-
mediated motility, and quorum sensing systems [12,13]. The
mechanism by which Vfr regulates all of these virulence factors is
not entirely known. A consensus DNA binding sequence has been
identified but does not fully explain every gene regulated by Vfr
[14]. To add further complexity, recent data suggests that Vfr may
control expression of some genes in a cAMP-independent manner
[15].
cAMP levels are regulated by synthesis and degradation [16,17].
In P. aeruginosa, two adenylate cyclases have been described that
synthesize cAMP. CyaB, a membrane bound adenylate cyclase,
plays the major role in cAMP synthesis, while CyaA, a cytoplasmic
adenylate cyclase, plays a minor role in synthesis [12,18].
Accordingly, CyaB is an important regulator of Vfr-dependent
functions; DcyaB and Dvfrmutants exhibit attenuated virulence in a
mouse model of acute pneumonia infection [19].
We previously carried out a transposon-mediated genetic screen
to identify P. aeruginosa genes important for host cell cytotoxicity.
This screen identified TFP, ExoU, and T3SS components as
critical mediators of host cell death [20,21]. Subsequent studies
have also shown that TFP and the T3SS are important virulence
factors in mouse models of acute P. aeruginosa infections [20,22,23]
and that the presence of a functional T3SS correlates with
unfavorable clinical outcomes in acute human infections [24].
Our genetic screen also identified a protein, FimL, with
homology to the N-terminus of a P. aeruginosa CheA homolog,
ChpA [25]. In addition to the hybrid kinase ChpA, the Chp
operon encodes two CheY homologs as well as other components
of the chemosensory system and regulates pilin extension and
retraction [26]. We demonstrated that FimL was important in
regulating TFP function, production and secretion of T3SS
associated virulence factors, biofilm formation, and concluded
that FimL likely functions upstream of Vfr. Spontaneous
extragenic suppressors of FimL, which arose at higher than
expected frequencies, regained TM and T3SS-mediated cytotox-
icity towards mammalian cells. One suppressor mutant was
analyzed in greater detail and found to produce nearly ten-fold
higher levels of cAMP compared to the parent strain [25] although
the site of the extragenic mutation(s) remains unknown. Together,
these results suggest that FimL and Vfr are components of
intersecting pathways that serve to regulate diverse virulence
factors involved in acute infections.
In this study, we performed genetic and physiologic experiments
to further define the mechanism of action of FimL. In a transposon
mutant screen designed to identify extragenic suppressors of FimL,
we found a cAMP-specific phosphodiesterase, suggesting that
FimL regulates cAMP levels. We measured cAMP levels in the
DfimL mutant and found decreased levels of cAMP, similar to the
diminished levels observed in DcyaB. By constructing informative
double and triple mutants in cyaA, cyaB, cpdA and fimL, we show
that DfimL mutants resemble DcyaB mutants with respect to altered
TM, decreased T3SS transcription, and decreased cAMP levels.
Epistasis experiments suggest that FimL function is CyaB
dependent. Similar to some of the virulence factors regulated by
cAMP, including TFP [27], flagella [28], and potentially the
T3SS, FimL and CyaB are polarly localized. While this
manuscript was in preparation, it was reported that FimL and
other components of the Chp operon also modulate cAMP levels
[29]. Together, these results suggest that the Chp system not only
regulates pilin function but also coordinately regulates cAMP-
dependent pathways, including the T3SS. We hypothesize that
FimL plays a pivotal role in this coordinate regulation by
interfacing with the Chp chemosensory system, TFP, and the
cAMP/Vfr pathway. Our studies reveal new complexities in the
regulation of diverse virulence pathways associated with acute P.
aeruginosa infections.
Materials and Methods
Bacterial Cultures and Assays
The bacterial strains and plasmids used in this study are
described in Table S1. Bacteria were routinely streaked onto on
Luria-Bertani (LB) 1.5% agar and grown in liquid LB overnight
shaking at 250 rpm at 37uC. E. coli strains S17.1 and SM10 were
used as donor strains with P. aeruginosa recipient strains in bacterial
conjugation. After mating with E. coli, P. aeruginosa strains were
selected by growth on 1.5% Difco Pseudomonas isolation agar
(Becton Dickinson). Antibiotic concentrations used for E. coli,
tetracycline, 5 mg/mL; ampicillin, 100 mg/mL; gentamicin,
10 mg/mL; kanamycin 50 mg/mL and for P. aeruginosa, tetracy-
cline, 100 mg/mL, carbenicillin 250 mg/mL, gentamicin, 100 mg/
mL. For b-galactosidase experiments and cAMP assays, bacterial
frozen stocks were freshly streaked onto LB agar, and following
overnight growth were inoculated into 5 mL of MinS media [30]
with or without addition of CaCl2 to a final concentration of
2 mM. Following growth overnight, samples were processed.
b-galactosidase assays were performed as previously described
[25].
cAMP assays were performed using the Cayman cAMP EIA
assay kit. Briefly, a volume of culture corresponding to 10 OD600
units was pelleted, and resuspended in 500 mL 0.1 M HCl.
Following 30 seconds of sonication, the debris was removed with a
low-speed spin after 10 min at 1000 X G for PA103 or 14,000 X
G for PAO1 strains. 400 mL of supernatant was transferred to a
fresh tube containing an equal volume of EIA buffer (supplied with
kit), and the samples were further processed according to the
manufacturer’s manual. For acetylated reactions, samples were
processed as above, except that the 500 mL of supernatant
(following sonication and pelleting) was acetylated according to
manufacturer’s protocol prior to dilution in EIA buffer and further
processing.
Transposon Mutagenesis
The donor strain SM10-l pir containing pBT20 was mated
with the recipient strain PAO1DfimL::CTXPexoT-lacZ. Transfor-
mants were plated on 1.5% LB agar plates containing bromo-
chloro-indolyl-galactopyranoside (40 mg/mL) and gentamicin and
screened for restoration of TM and blue colony color. Insertion
sites were determined using semirandom PCR [31].
Twitching Motility assays were performed using the subsurface stab
assay as previously described [26].
Plasmid construction
All plasmids were purified using Qiagen kits and standard
molecular biology recombinant techniques were used. Enzymes
were purchased from New England Biolabs and used as
recommended by the manufacturer. All primers used in construc-
tion were designed using the PAO1 genome (www.pseudomonas.
FimL Regulates cAMP Synthesis
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com) and synthesized by Qiagen or Elim Biopharmaceuticals, Inc.
Primer sequences are available upon request.
Construction and complementation of in-frame deletion
mutants
All matings were performed as described previously [26]. In
general, a PCR fragment 1 kb upstream of the target deletion gene
and 1 kb downstream was synthesized and overlap PCR
performed to create the deletion PCR fragment. This fragment
with created with unique restriction enzyme sites on both ends and
cloned into pJB100T or pEX100T. This plasmid was then
introduced into S17.1 E. coli strain and mated to P. aeruginosa. The
vector backbone was then counter-selected using 5% sucrose-
containing 1.5% LB agar plates and the resulting unmarked
deletion strain was checked with PCR and/or Southern blot.
Construction of CTX-exoT-lacZ strains
The promoter region (600 bp upstream of the exoT gene) was
directionally cloned into the mini-CTX-lacZ vector as a HindIII-
EcoR1 fragment, following amplification from genomic DNA with
the primers 59AAGCTTCCACGCCTGACATCGCTCAC 39
and 59GAATTCGCCACGAAAGACGGGTTCTG 39. The re-
sulting CTX-PexoT-lacZ plasmid was mated into wild type PAO1 to
generate PAO1::CTXPexoT-lacZ. The DfimL derivative was gener-
ated by mating the DfimL allelic exchange plasmid pJEN36 into
PAO1::CTXPexoT-lacZ. The Dvfr derivative was generated by
mating pJEN51 into PAO1::CTXPexoT-lacZ. PA103 versions of
these strains were also generated with these plasmids.
Construction of chromosomal and plasmid-borne
FimL3X-FLAG strains
A C-terminal triple FLAG-tagged version of fimL, containing a
diagnostic Cla1 restriction site was constructed as follows. Using
primers 59CGGGATCCCCGGCCCGGCCAGCCATAGCAG-
CAGGGGG-39 and 59CCATCGATTTTATCGTCATCGTCT-
TTGTAGTCGGCGGCTTTATCGTCATCGTCTTTTAGTC-
GGCGGCCACCGGCAGTCCGA -39, a 3 kb fragment contain-
ing a BamH1 site followed by 1 kb of sequence upstream of fimL,
the fimL coding region immediately upstream of the stop codon,
and 2 FLAG tags followed by Cla1 site was amplified. Separately,
primers 59CCATCGATGACTACAAAGATGACGATGACAA-
ATGATGGCCGGCGAGTTCCGCTGGC-39 and 59- GCTCA-
GACGGAGCGTTCTGGACCGTGACCTC-39 were used to
amplify a fragment containing a Cla1 site, followed by a single
FLAG tag, the stop codon, and 1 kb of sequence downstream of
fimL, terminating with an Xba1 site. The amplicons were digested
respectively with BamH1 and Cla1, and Cla1 and Xba1, ligated
together into pOK12 that had been digested with BamH1 and
Xba1. The resulting triple FLAG-tagged fimL fragment was
excised with Spe1 and cloned into the allelic exchange vector
pJB100T. The resulting plasmid pJTW019 was mated into
PAO1DfimL::CTXPexoT-lacZ. The complemented fimL mutant
was confirmed to carry the triple flag-tagged fimL by PCR/Cla1
digest, and functional complementation was confirmed by
Western blot using an anti-Flag monoclonal antibody (Sigma).
The insert from pJW019 was subcloned as a Spe1 fragment into
the Xba1 site of pUCP19Dlac. A BamH1 digest was performed to
identify which clones were in the correct orientation to be
expressed from the pTac promoter. The resulting plasmid
pUCP19-fimL3X-FLAG was transformed into P. aeruginosa strains
(see Table S1); expression from the plasmid was confirmed by
Western blot.
Construction of FimL-GFP strains
fimL was PCR amplified using 59 TGGGCTAGCGAATT-
CATGGTCACAGGAGCC and 59 GGACTGCCGGTGGCC-
GCCGGCGGCGGCAAGCTTGTGAGCAAG with a 3XGly
linker, minus the STOP codon and cloned into pMBAD-GFP to
generate pYFI007. fimL-GFP was subcloned from pYFI007 into
PJB100T by overlap PCR with a PCR fragment downstream of
fimL on the PAO1 chromosome and was amplified using primers
59 CGGCATGGACGAGCTGTACAAGTAATGGCCGGCG-
AGTTCCGCTGGC and 59CAGGGTAATACTAGTAGCG-
GCGCGCCAGGTAC to generate the fimL-GFP gene replace-
ment construct pYFI043. Similarly, cyaB was amplified using 59
GCTAGCGAATTCATGAAGCCTACCCTCCCCGACC 39 and
59 CCCCGGGTACCGCCGCCGCCGAGGATGACCTTGT-
CGCGCAGG39 to generate pYFI184.
SDS-PAGE and immunoblotting assays were performed as in [32].
Results
A screen for extragenic suppressors of fimL identifies the
phosphodiesterase CpdA
To further understand how FimL controls virulence pathways,
we devised a genetic screen to identify new regulators in the FimL
pathway. Our goal was to find single gene disruptions that resulted
in restoration of TFP function and T3SS function in a DfimL
mutant. Therefore, we screened a library of transposon insertions
in a DfimL strain for mutants that simultaneously regained TM and
T3SS function. Specifically, we utilized a mariner transposon [33]
to mutagenize PAO1DfimL containing an E. coli lacZ gene reporter
fused to the promoter of the T3SS effector exoT (denoted PexoT-
lacZ). Approximately 100,000 transposon mutants (approximately
20X genome coverage) were visually screened on LB plates
containing bromo-chloro-indolyl-galactopyranoside (X-gal) and
isopropyl b-D-1-thiogalactopyranoside (IPTG) for simultaneous
recovery of exoT transcription (as evidenced by blue colonies) and
TFP function (as evidenced by TM, a phenotype readily visible as
a colony with an expanding edge). From this screen, we recovered
a transposon insertion in PA4969, which regained PexoT-lacZ
expression and TM in the DfimL background. We constructed an
in-frame deletion of PA4969 in PAO1DfimL (PAO1DfimLDcpdA)
and confirmed that inactivation of PA4969 was responsible for
suppressing the DfimL phenotype. PAO1DfimLDDcpdA showed
high PexoT-lacZ expression (Fig. S1A) and partially restored TM
(Fig. S1B). During the preparation of this manuscript, PA4969 was
characterized as a cAMP- specific phosphodiesterase, CpdA [34].
FimL regulates cAMP levels
Since disrupting cpdA restored TM and T3SS function in the
DfimL mutant, we predicted that DfimL mutants would have
decreased levels of cAMP. To test this hypothesis, we measured
bacterial cAMP. The experiments were performed in the presence
and absence of calcium, since minimal media lacking calcium
induces expression of T3SS gene expression [35]. We previously
reported that cAMP levels were barely detectable in the wild type
PAO1 strain [25], however with protocol changes we were able to
reproducibly measure cAMP in PAO1. In the absence of calcium,
we observed an ,80% decrease in cAMP levels in the DfimL
mutant compared to PAO1 (Fig. 1A; P,0.001). As controls, we
assayed PAO1DcyaA, PAO1DcyaB, and the double mutant
PAO1DcyaADcyaB. No significant difference was observed in
cAMP levels in the DcyaA strain when compared to wild type.
However the DcyaB and DcyaADcyaB mutants showed an ,85%
and ,95% decrease, respectively, in cAMP levels when compared
to wild-type (P,0.001). The low cAMP levels observed in
FimL Regulates cAMP Synthesis
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PAO1DcyaB, PAO1DfimL and PAO1DcyaADcyaB were not statis-
tically different from each other. Together, these results suggest
that FimL modulates cAMP levels.
Deletion of the phosphodiesterase gene (PAO1DcpdA) resulted in
an approximately 100-fold increase in cAMP levels compared to
wild type (Fig. 1A). Thus we reasoned that we could detect
changes in cAMP levels very robustly in a sensitized mutant
background in which cpdA was inactivated. We therefore
constructed in-frame deletions of fimL, cyaA, and cyaB in the
phosphodiesterase mutant background PAO1DcdpA and measured
cAMP levels. As shown in 1B, deletion of fimL (PAO1DcpdADfimL)
or cyaB (PAO1DcdpADcyaB) resulted in ,50% (P,0.001) and
,75% (P,0.001) decrease in cAMP levels, respectively, compared
to PAO1DcdpA, while no statistically significant decrease was
observed in the cyaA mutant (PAO1DcpdADcyaA). cAMP was
undetectable in the PAO1DcpdADcyaADcyaB mutant, confirming
that CyaA and CyaB are the only source of cAMP in this strain.
Altogether, the trends in cAMP levels in PAO1 or the PAO1DcpdA
background are similar, lending further support to our conclusion
that FimL regulates cAMP levels.
To ascertain if these results were strain-specific, we constructed
in-frame deletion mutants in PA103. We reproducibly detected
,10-fold decrease in cAMP levels in PA103DfimL and PA103
DcyaB compared to PA103 (Fig. 1C; P,0.001). The levels of
cAMP were restored to near wild type levels in the PA103DfimL
strain complemented with FimL-3X-FLAG at the endogenous
locus (Fig. S2). As expected, in PA103DcyaA, cAMP levels were
indistinguishable from wild type PA103, and cAMP was
undetectable in the PA103DcyaADcyaB mutant (Fig. 1C). Thus,
deletion of fimL correlates with a decrease in cAMP levels in both
PAO1 and PA103, strongly supporting a role for FimL in cAMP
production in P. aeruginosa.
FimL promotes CyaB-dependent cAMP synthesis
FimL regulation of cAMP could occur by affecting cAMP
synthesis or by stimulating degradation of cAMP via the
phosphodiesterase CpdA. If FimL only functions through CpdA
activity, then cAMP levels should not change between the DcpdA
and the DcpdADfimL mutants. As shown in Fig. 1B, cAMP levels
are reduced in PAO1DcpdADfimL compared to PAO1DcpdA,
suggesting that FimL regulates cAMP independent of CpdA.
We therefore considered the alternative model that FimL
regulates cAMP biosynthesis and compared cAMP levels in the
presence or absence of FimL in PAO1DcyaA, PAO1DcyaB, and
PAO1DcyaADcyaB (Fig. 1A). cAMP levels decreased ,90% in
PAO1DcyaADfimL compared to PAO1DcyaA (P,0.001). In
contrast, there was no statistically significant difference in cAMP
levels between PAO1DcyaB and PAO1DcyaBDfimL or between
PAO1DcyaADcyaB and PAO1DcyaADcyaBDfimL. In the DcyaADfimL
mutant, CyaB is the only source of cAMP; thus, the decrease in
cAMP levels in this mutant compared to the DcyaA mutant
suggests that FimL affects cAMP synthesis via CyaB. The finding
that cAMP levels are indistinguishable between DcyaBDfimL and
DcyaB also suggests that FimL does not act through CyaA. Similar
results were observed with deletion mutants in the PAO1DcpdA
background (Fig. 1B).
FimL does not affect cyaB transcription or protein levels
Our results so far suggest that FimL modulates cAMP levels
through CyaB. This regulation could occur by modulating cyaB
transcription, CyaB protein levels, or CyaB activity. To determine
whether cyaB expression was altered at the transcriptional level, we
compared the b-galactosidase activity of the lacZ gene fused to the
promoter of cyaB and integrated into the chromosome at the CTX
site in PAO1 and PAO1DfimL. As shown in Fig. 2, there was no
difference in transcription from the cyaB promoter in the wild type
or the DfimL background. Minimal transcription of the lacZ
Figure 1. cAMP levels are decreased in fimL mutants. Intracel-
lular cAMP levels were measured in the presence (2 mM) or absence of
calcium in (A) PAO1, (B) PAO1DcpdA, or (C) PA103. Gene names denote
in-frame deletions. PAO1DcpdA(comp) fimL-FL denotes complementa-
tion of PAO1DcpdADfimL with fimL-3X-FLAG by gene replacement in the
fimL locus. PAO1DcpdADcyaB (CTX-cyaB) denotes complementation of
PAO1DcpdADcyaB with cyaB at the CTX phage attachment site. Note
the scale differences. Shown are mean results of triplicate samples from
3 experiments. Error bars indicate SD (for cpdA in (A) +/24.7 in the
presence of Ca2+ and +/23.6 in the absence of Ca2+). (***) P,0.001
compared to the wild type strain grown in the absence of calcium.
doi:10.1371/journal.pone.0015867.g001
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reporter was observed in the absence of the cyaB promoter. In
contrast to strain PAK in which cyaB transcription was reported to
be calcium dependent in microarray analysis [12], we did not
observe calcium-dependent cyaB transcription in PAO1.
We next assayed CyaB protein production in a strain in which
the native cyaB gene was replaced with a cyaB-His fusion. As shown
in Fig. 2B, protein levels of CyaB-His were unaltered in
PAO1DfimL. We therefore conclude that FimL modulates CyaB
function at a post-translational step.
Expression of T3SS genes correlates with intracellular
cAMP levels
We previously published that fimL mutants exhibited decreased
ExoT production and secretion [25]. vfr mutants were also shown
to be defective in T3SS function [12]. Together with published
data and given our cAMP results, we predicted that fimL mutants
would show decreased transcription of T3SS genes. We used our
panels of isogenic mutants to directly assess the role of FimL and
cAMP on the transcription of a representative T3SS gene, the
secreted toxin ExoT. This readout is robust and can readily be
detected in either PA103 or PAO1.
A transcriptional fusion comprising the exoT promoter fused to
lacZ (PexoT-lacZ) was integrated at the CTX phage attachment site
in DfimL, DcyaA, and DcyaB mutants in PAO1 (Fig. 3A) and PA103
(Fig. 3B) and assayed for b-galactosidase activity in the presence or
absence of calcium. We reproducibly found a correlation between
cAMP levels and PexoT-lacZ transcription. Compared to wild type
PAO1 or PA103, PexoT-lacZ transcription was unaffected in the
PAO1DcyaA mutant or PA103DcyaA mutant, respectively. In
contrast, the corresponding DfimL and the DcyaB mutants showed
greatly reduced PexoT-lacZ expression, similar to the levels seen in
the Dvfr and DcyaADcyaB mutants. PexoT-lacZ transcription in
PAO1DfimL and PA103DfimL was restored to wild type levels
upon complementation with fimL (Figs. 3A and 3B).
TM correlates with cAMP levels
Assembly and function of TFP requires over 40 gene products
whose transcription is regulated in part by Vfr [3], therefore we
predicted that cAMP would also regulate TM. We measured TM
of DcyaA, DcyaB, DfimL and Dvfr mutants in PAO1 and PA103 by
the subsurface stab assay. All mutants that exhibited decreased
cAMP levels (Fig. 1) and decreased PexoT-lacZ expression (Figs. 3A
and 3B) also showed reduced TM, including DfimL, DcyaB,
DcyaADfimL, DcyaBDfimL, and DcyaADcyaB mutants in both the
PAO1 (Fig. 3C) and PA103 (Fig. 3D) backgrounds. TM was
restored to the wild type diameter upon complementation of the
corresponding DfimL mutant.
Ectopic expression of fimL reduces cAMP levels
We tested the effect of ectopic expression of fimL on cAMP
levels and cAMP-dependent phenotypes. FimL-FLAG was cloned
into a plasmid under the control of a constitutive promoter
(pUCP19Dlac), denoted ‘‘pfimL-FL’’ and introduced into PAO1,
PAO1DcpdA, and PA103. We confirmed that the addition of the
epitope tag did not affect FimL function by demonstrating that
fimL-FL restored cAMP production in PAO1DcpdA (Fig. 1B) and in
PA103DfimL (Fig. S2). Expression of the empty vector had no
effect on cAMP levels; however, expression of pfimL-FL resulted in
decreased levels of cAMP in PAO1DcpdA and PAO1DcpdADcyaA
compared to the corresponding isogenic strain containing the
control vector (Fig. 4A). Similar results were observed when pfimL-
FL was introduced into PA103 (Fig. 4B) and PAO1 (data not
shown) suggesting that the decreased cAMP levels upon ectopic
expression of fimL are not strain-specific. Expression of pfimL-FL
did not affect PcyaB-lacZ expression (Fig. S3), indicating that the
inhibitory effect of FimL is not through cyaB transcription.
Expression of pfimL-FL in PAO1DcyaB or PA103DcyaB did not
significantly change the already low levels of cAMP in these
strains.
Given these findings, we predicted that ectopic expression of
fimL would also affect TM and transcription of T3SS genes. As
shown in Fig. S4, ectopic expression of pfimL-FL inhibited TM in
PAO1. Likewise, ectopic expression of pfimL-FL decreased PexoT-
lacZ expression in PAO1 (Fig. 5A) and PA103 (Fig. 5B) and in the
corresponding DcyaA mutants. As expected from previous
experiments, ectopic expression of pfimL-FL in PA103DcyaB did
not further decrease the already low levels of PexoT-lacZ
transcription, supporting the hypothesis that the regulation of
cAMP by FimL is CyaB-dependent.
Together, these results suggest that precisely tuned levels of
FimL are critical to modulate cAMP levels. It is possible that in
order to promote cAMP synthesis efficiently, the stoichiometry of
FimL:CyaB is critical. However, FimL is not absolutely required
Figure 2. Loss of fimL does not affect cyaB transcription or
protein levels. (A) b-galactosidase activity was measured in the
presence or absence of calcium in PAO1 or PAO1DfimL. All strains carry
a lacZ transcriptional reporter integrated at the CTX site without a
promoter (P0-lacZ) or with the cyaB promoter (PcyaB-lacZ). Error bars
indicate SD of the average rate from 14 data points taken from two
experiments. (B) Immunoblot of PAO1 or PAO1DfimL in which the wild
type cyaB gene has been replaced with cyaB-His. Lysates were prepared
from bacteria grown in the presence or absence of Ca2+ and probed
with anti-His antibody (upper panel) or anti-PilA antibody (lower panel)
as a loading control.
doi:10.1371/journal.pone.0015867.g002
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for CyaB function, as some cAMP is synthesized in the absence of
FimL (Fig. 1). Consistent with these observations, we found that
expression of pcyaB can complement the PAO1DfimL mutant for
T3SS function (Fig. S5). We propose that FimL is required for
optimal CyaB adenylate cyclase activity.
FimL and CyaB are polarly localized
Many of the virulence factors that are regulated by FimL, such
as TFP and potentially the T3SS, are polarly localized in
Enterobacteriaceae. We therefore investigated the localization of
FimL and CyaB. For our initial studies, we constructed a plasmid-
borne fimL-GFP fusion under control of an arabinose inducible
promoter (pfimL-GFP) and introduced the plasmid into PAO1 or
PAO1DfimL. In the absence of arabinose induction, low-level
expression of fimL-GFP was sufficient to restore TM in PAO1DfimL
(Fig. S6A), confirming that fusion to GFP did not interfere with
FimL function. When fimL-GFP was induced with arabinose, TM
and cAMP levels were inhibited compared to the control strain
carrying a GFP-expressing plasmid (PAO1-pGFP) (Figs. S6A and
S6B). Fluorescence microscopy of log-phase PAO1DfimL+pfimL-
GFP grown in the presence (data not shown) or absence of
arabinose (Fig. 6D) revealed that FimL-GFP localized to both
poles of the cell. Images of stationary phase PAO1DfimL+pfimL-
GFP induced with arabinose show an apparent decrease in the
frequency of polarly localized puncta (Fig. 6E), suggesting that
overexpression of fimL leads to FimL protein delocalization and
subsequent interference with function. Since overexpression of
GFP fusion proteins can lead to artifactual localization [36], we
replaced the native fimL locus with fimL-gfp. Expression of fimL-
GFP from a single copy gene at the native locus restored TM and
cAMP production (Figs. S6A and S6B) and exhibited polar
localization regardless of growth phase (for representative images
see Figs. 6A and 6B).
To examine whether CyaB is also polarly localized, we
generated the strain PAO1DcyaB + pcyaB-GFP. With arabinose
induction, TM was restored to wild type levels (Fig. S6C), and
microscopy shows bipolar localization of CyaB-GFP and a strong
signal around the perimeter of the cell in the absence (data not
shown) or the presence of arabinose (Fig. 6F) from log-phase
grown cells. Together, these results suggest that both FimL and
CyaB are polarly localized.
Discussion
cAMP is increasingly appreciated as an important regulator of
diverse pathways in many bacteria. In P. aeruginosa, it is involved in
the coordinate regulation of many critical virulence factors. CyaB,
and a cAMP-dependent transcriptional regulator, Vfr, regulate the
expression of over 200 genes, including components of the T3SS,
TM, the T2SS, flagellar motility, and quorum sensing [12].
Through genetic and physiologic analyses, we demonstrate that
Figure 3. FimL, CyaB, and Vfr are required for exoT transcription and TM. All strains harbor the PexoT-lacZ transcriptional reporter fusion
integrated at the CTX site as a readout for transcription of the T3SS. b-galactosidase activity was measured in the presence or absence of calcium.
Gene names denote in-frame deletions in PAO1 (A and C) or PA103 (B and D). (A and B) Shown are mean of 12 data points from triplicate samples
from 2 or 3 experiments. (C and D). Shown is the mean diameter from a minimum of 5 colonies from 2 or 3 experiments. Error bars denote SD.
(***) indicates P,0.001 compared to the wild type strain grown in the absence of Ca2+.
doi:10.1371/journal.pone.0015867.g003
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FimL, a protein with two histidine phosphotransfer (Hpt) like
domains, is required for optimum CyaB-dependent biosynthesis of
cAMP. Additionally, we find that both FimL and CyaB are polarly
localized, suggesting that spatial regulation of cAMP production
may be important to the virulence of P. aeruginosa. Overexpression
of fimL inhibits cAMP production and may cause FimL to
mislocalize. We note that Fulcher et al. found that a disruption in
fimL decreased cAMP levels in the P. aeruginosa strain PAK [29],
suggesting this function in relevant across Pseudomonad species.
How might FimL contribute to cAMP production? Our
experiments eliminate the possibility that FimL is required to
maintain protein levels of CyaB in PAO1 or PA103, as no
decrease in cyaB transcription or CyaB protein levels were
observed in fimL mutants. Another possibility is that FimL
enhances the adenylate cyclase activity of CyaB. In support of
this hypothesis, epistasis experiments suggest that FimL and CyaB
function in the same pathway. Our finding that both FimL and
CyaB are polarly localized indicates that they may function as a
complex. A simple hypothesis is that FimL is required for CyaB
localization and/or CyaB is required for FimL localization.
However, preliminary experiments suggest that their interactions
may be more complicated, as FimL is still polarly localized in
DcyaB mutants, and CyaB is polarly localized in the DfimL mutant
(unpublished data). Interestingly, we have recently reported that
CbpA, a cAMP binding protein of unknown function, is also
localized to the poles [37]. An attractive possibility is that localized
Figure 4. Ectopic expression of fimL decreases cAMP. cAMP
levels were measured in (A) PAO1DcpdA or (B) PA103 with p (empty
vector) or pfimL-FL (vector with fimL-3X-FLAG). Shown are mean values
of 3 experimental repetitions performed in triplicate. Error bars indicate
SD. (***) P,0.001 compared to the respective strains containing vector
only and grown in the absence of Ca2+.
doi:10.1371/journal.pone.0015867.g004
Figure 5. Ectopic expression of fimL inhibits exoT transcription.
All strains harbor the PexoT-lacZ transcriptional reporter fusion
integrated at the CTX site as a readout for transcription of the T3SS
and either include p (vector only) or pfimL-FL (vector with fimL-3X-
FLAG). b-galactosidase activity was measured in the presence or
absence of Ca2+ in the indicated mutants in (A) PAO1 or (B) PA103.
Shown is the mean of 12 data points from 3 or 4 experiments. Error bars
indicate SD. (***) P,0.001 compared to the respective strain containing
vector only grown in the absence of Ca2+.
doi:10.1371/journal.pone.0015867.g005
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regulation of cAMP is important in regulating polar proteins.
Indeed, spatial gradients of another second messenger signaling
molecule, c-di-GMP, which is important for biofilm formation and
swarming motility, have been recently reported [38].
FimL shares homology with the N-terminal 563 amino acids of
the 2477 amino acid ChpA protein, and it is tempting to speculate
that binding interactions between FimL and ChpA or ChpA
binding partners are important for regulating CyaB and/or other
components of the cAMP regulatory circuit. ChpA is one of the
most complex CheA homologs yet described, with 8 potential Hpt
domains and a CheY-like domain [26]. Work from several labs
suggests that the histidine kinase domain, the CheY domain, and
at least two of the Hpt domains, are required for TM in PAO1
[32,39]. Notably, glutamine (rather than histidine) is found at the
two putative FimL phosphoryl group acceptor sites; hence it is
unlikely that FimL is capable of phosphotransfer in a canonical
manner. One possibility is that FimL, ChpA, and CyaB form a
polarly localized complex to allow spatial, environmental, and
temporal production of cAMP that regulates multiple polarly
localized structures, including TFP and the T3SS (see Fig. 7).
ChpA is thought to be the central histidine kinase of a larger
regulatory circuit with homology to chemosensory signal trans-
duction systems. This module includes PilJ, a putative methyl-
accepting chemotaxis protein; PilK, a methyltransferase homolog,
2 CheW homologs (PilI and ChpC); ChpB, a methylesterase
homolog; and two additional CheY-like response regulators (PilG
and PilH). PilJ, PilK, PilI, PilG, and PilH are required for TM.
Fulcher and co-workers recently reported that disruption of chpA,
pilJ, or pilG decreased cellular cAMP levels through a CyaB-
dependent mechanism, whereas loss of pilH resulted in increased
cAMP levels [29]. In conjunction with our finding that FimL also
promotes cAMP production in a CyaB-dependent manner (this
work) and that overexpression of either fimL (this work and [26]) or
chpA [26] impairs cAMP-dependent pathways such as TM, we
Figure 6. FimL and CyaB are polarly localized. Images of (A) log-phase or (B) stationary phase grown PAO1 fimL-GFP in which fimL-gfp replaced
the native fimL gene. Scale bar is approximately 10 mm. (C) PAO1 GFP with pGFP (stationary phase). (D) PAO1 DfimL + pfimL-GFP without arabinose
induction (log phase). (E) PAO1 + pfimL-GFP with arabinose induction (stationary phase). (F) PAO1 DcyaB + pcyaB-GFP with arabinose induction (log
phase).
doi:10.1371/journal.pone.0015867.g006
Figure 7. FimL may function to link the Chp system and CyaB
to regulate cAMP levels in P. aeruginosa. FimL may interact with
ChpA and/or CyaB to affect cAMP biosynthesis activity directly or
indirectly. The Chp chemosensory system is thought to regulate pilus
extension and retraction via two-component signaling. An input signal
to the methyl-accepting chemotaxis protein PilJ induces autopho-
sphorylation of the hybrid histidine kinase ChpA. PilG and PilH are
putative response regulators that accept phosphoryl groups from
phosphorylated ChpA and regulate pilus function. CpdA is a
phosphodiesterase that degrades cAMP. cAMP is an allosteric regulator
of Vfr which regulates multiple virulence pathways. OM and IM refer to
the outer membrane and inner membrane respectively.
doi:10.1371/journal.pone.0015867.g007
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propose that FimL could link the Chp system and CyaB activation
to promote cAMP synthesis (Fig. 7). This interaction may involve
direct interactions between FimL and ChpA. Because ChpA
contains 8 potential Hpt domains, there are many potential
activation states that ChpA might occupy, allowing fine-tuning of
response to environmental stimuli and subsequent downstream
signaling. Interactions between FimL and ChpA could influence
ChpA activity and affect downstream ChpA signaling.
An important strength of our studies is that we verified critical
observations in two different strains. Our work demonstrates that
in PAO1 and PA103, the cAMP defects in the DfimL and DcyaB
mutants translate to defects in the Vfr-cAMP mediated functions,
including decreased T3SS transcription and TFP-mediated
motility. This finding contrasts the reported near wild type TM
of PAKDcyaB [12] and PAKDfimL [25] despite the decreased
cAMP levels in these mutants [29]. These differences suggest that
additional or different factors may regulate TM in the PAK strain
background. In addition, whereas cyaB transcription is reported in
PAK to be induced under low calcium conditions [12], we
observed that transcription and protein levels of CyaB were similar
under calcium-poor and calcium-replete conditions.
We note some subtle differences between PAO1 and PA103
with respect to cAMP-mediated functions. PexoT-lacZ transcription
was relatively insensitive to calcium in PA103, even though
production and secretion of the T3SS effectors is induced in
calcium-poor media. In contrast, PexoT-lacZ transcription in PAO1
was induced in media lacking calcium. These differences may
reflect strain-specific fine-tuning of virulence circuits.
In summary, using a genetic screen and physiologic studies, we
provide evidence that FimL regulates CyaB activity and cAMP
production at a post-translational step and that both proteins
exhibit polar localization. Future studies will be directed at
determining the mechanism and role of the polarly localized
cAMP biosynthesis and spatial regulation of virulence circuits.
Supporting Information
Figure S1 Deletion of cpdA enhances exoT expression and TM in
DfimL. (A) All strains harbor the PexoT-lacZ transcriptional reporter
fusion as a read-out for transcription of the T3SS. b-galactosidase
activity was measured in the presence or absence of Ca2+. Gene
names denote in-frame deletions in PAO1. The results are
normalized to wildtype values measured in the absence of Ca2+.
Shown is the mean +/2 SD of 12 data points of triplicate samples
from 2 or 3 experiments. (B) Shown is the average colony diameter
+/2 SD from 8 colonies of a TM assay. (***) P,0.001, (**) P,0.01.
(TIF)
Figure S2 fimL-3X-FLAG restores cAMP production compared
to DfimL.
(TIF)
Figure S3 Ectopic expression of pfimL-FL does not affect cyaB
transcription. b-galactosidase activity was measured in the
presence or absence of Ca2+ in PAO1 or PAO1 expressing
pfimL-FL. Shown is the mean of three experiments. Error bars
indicate SD.
(TIF)
Figure S4 Loss or ectopic expression of pfimL inhibits TM.
Shown are representative colonies of the indicated strains. p
denotes the empty vector and pfimL-FL denotes the vector with the
fimL-FL insert.
(TIF)
Figure S5 Ectopic expression of cyaB restores PexoT-lacZ
transcription in a DfimL mutant. All strains harbor the PexoT-
lacZ transcriptional reporter fusion integrated at the CTX site as a
readout for transcription of the T3SS. b-galactosidase activity was
measured in the presence or absence of Ca2+ in PAO1,
PAO1DcyaB, or PAO1DfimL carrying the empty vector (p) or a
vector with cyaB (pcyaB). Shown is the mean of 3 experiments
performed in triplicate. Error bars indicate SD.
(TIF)
Figure S6 FimL-GFP is functional. (A) Colony diameter
measurements showing TM in PAO1 and PAO1DfimL, with GFP
plasmid (pGFP) or with pfimL-GFP grown in the presence or absence
of the inducer arabinose. Arabinose induction of pfimL-GFP inhibits
TM in PAO1 and in PAO1DfimL. Shown are the mean of at least 8
measurements. (B) cAMP measurements of the strains described in
A. (C) Colony diameter measurements in DcyaB or DcyaB +pcyaB-
GFP. Error bars indicate SD. (***) P,0.001 (*) P,0.5
(TIF)
Table S1 Strains and plasmids.
(DOC)
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